Penbrook Management’s AMERICAN BIO MEDICA CORP ABMC Stock Holding History

Penbrook Management’s Portfolio ABMC Stock Details ABMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-41,500	Closed	-$44K	–	106
2020 Q2	$44K	Buy	+41,500	New	+$44K	0.04%	99
2016 Q3	$33K	Buy	+252,500	New	+$33K	0.04%	106
2016 Q1	–	Sell	-255,500	Closed	-$33K	–	113
2015 Q4	$33K	Sell	255,500 -20,000	-7%	-$2.58K	0.03%	116
2015 Q3	$36K	Hold	275,500	–	–	0.04%	112
2015 Q2	$31K	Hold	275,500	–	–	0.03%	106
2015 Q1	$30K	Hold	275,500	–	–	0.03%	115
2014 Q4	$36K	Sell	275,500 -99,814	-27%	-$13K	0.03%	116
2014 Q3	$46K	Hold	375,314	–	–	0.04%	118
2014 Q2	$49K	Sell	375,314 -375,314	-50%	-$49K	0.04%	114
2014 Q1	$91K	Buy	750,628 +375,314	+100%	+$45.5K	0.04%	116
2013 Q4	$49K	Buy	+375,314	New	+$49K	0.05%	108

Penbrook Management's ABMC Position: Q3 2020 in Review

Penbrook Management sold out of AMERICAN BIO MEDICA CORP (ABMC) in Q3 2020, closing a stake of 41,500 shares — an estimated $44K sold.

Penbrook Management first reported a position in ABMC in Q4 2013 and held it in 11 quarters. The position peaked at $91K in Q1 2014. 0 funds tracked by Wall St. Rank hold ABMC as of Q3 2020.

Penbrook Management reported no remaining AMERICAN BIO MEDICA CORP position as of Q3 2020 after selling out during the quarter.
Penbrook Management sold 41,500 AMERICAN BIO MEDICA CORP shares in Q3 2020, an estimated $44K.
Penbrook Management first reported a position in AMERICAN BIO MEDICA CORP in Q4 2013 and held it in 11 quarters.
Penbrook Management's AMERICAN BIO MEDICA CORP position peaked at $91K in Q1 2014.
0 funds tracked by Wall St. Rank held AMERICAN BIO MEDICA CORP as of Q3 2020.

Based on Penbrook Management's 13F filing for Q3 2020, filed 23 Oct 2020.